Jump to content
  • Sign Up
0
Scott Adams

Alvine Pharmaceuticals Announces Positive Results From Phase 2a Trial of ... - MarketWatch (press release)

Rate this topic

Recommended Posts

Alvine Pharmaceuticals Announces Positive Results From Phase 2a Trial of ...

MarketWatch (press release)

"There are currently no approved therapies for celiac disease. Strict, life-long adherence to a gluten-free diet (GFD) is the current standard of care and the only treatment option for these patients, but this does not offer a comprehensive solution," ...

and more »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×